BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 21942957)

  • 1. [Alternative therapy with ivabradine in patients with functional class III chronic heart failure].
    Kanorskiĭ SG; Tregubov VG; Pokrovskiĭ VM
    Kardiologiia; 2011; 51(8):39-44. PubMed ID: 21942957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Advantages of quinapril therapy in patients with arterial hypertension and functional class III chronic heart failure with preserved left ventricular ejection fraction].
    Kanorskiĭ SG; Tregubov VG; Pokrovskiĭ VM
    Kardiologiia; 2012; 52(4):31-7. PubMed ID: 22839514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Regulatory Adaptive Status in Assessment of Efficacy of Pharmacotherapy and Prognostication of Complications in Functional Class III Chronic Heart Failure].
    Tregubov VG; Kanorskiy SG; Pokrovskiy VM
    Kardiologiia; 2016 Jan; 56(1):12-17. PubMed ID: 28294725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical, hemodynamic and neurohumoral effects of switching patients with chronic heart failure from not recommended -adrenoblockers to bisoprolol in ambulatory practice].
    Ageev FT; Zhubrina ES; Ovchinnikov AG; Seredenina EM
    Kardiologiia; 2010; 50(6):41-7. PubMed ID: 20659026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ivabradine therapy on heart failure biomarkers.
    Ordu S; Yildiz BS; Alihanoglu YI; Ozsoy A; Tosun M; Evrengul H; Kaftan HA; Ozhan H
    Cardiol J; 2015; 22(5):501-9. PubMed ID: 25733317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Selective Heart Rate Slowing in Heart Failure With Preserved Ejection Fraction.
    Pal N; Sivaswamy N; Mahmod M; Yavari A; Rudd A; Singh S; Dawson DK; Francis JM; Dwight JS; Watkins H; Neubauer S; Frenneaux M; Ashrafian H
    Circulation; 2015 Nov; 132(18):1719-25. PubMed ID: 26338956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-Blockers and ivabradine differentially affect cardiopulmonary function and left ventricular filling index.
    Fischer-Rasokat U; Honold J; Lochmann D; Wolter S; Liebetrau C; Fichtlscherer S; Möllmann H; Spyridopoulos I; Hamm CW
    Clin Res Cardiol; 2016 Jun; 105(6):527-34. PubMed ID: 26687495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metoprolol vs ivabradine in patients with mitral stenosis in sinus rhythm.
    Agrawal V; Kumar N; Lohiya B; Sihag BK; Prajapati R; Singh TB; Subramanian G
    Int J Cardiol; 2016 Oct; 221():562-6. PubMed ID: 27420578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy and safety of long-term application of spironolactone in patients with moderate and severe chronic heart failure receiving optimal therapy].
    Skvortsov AA; Mareev VY; Chelmakina SM; Baklanova NA; Belenkov IuN
    Kardiologiia; 2007; 47(10):12-23. PubMed ID: 18260939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial Effect on Surrogate Markers of Heart Failure with Bisoprolol Up-Titration to Recommended Targets in Korean Patients with Heart Failure and Left Ventricular Systolic Dysfunction.
    Han SW; Choi SW; Ryu KH; Kim HJ; Kim SH; Shim WJ; Cha TJ; Choi DJ; Kim YJ; Yoo BS; Kim JH; Hwang KK; Jeon H; Shin MS
    Cardiovasc Ther; 2016 Jun; 34(3):172-9. PubMed ID: 27003232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of If-channel inhibition on hemodynamic status and exercise tolerance in heart failure with preserved ejection fraction: a randomized trial.
    Kosmala W; Holland DJ; Rojek A; Wright L; Przewlocka-Kosmala M; Marwick TH
    J Am Coll Cardiol; 2013 Oct; 62(15):1330-8. PubMed ID: 23916925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term residential cardiac rehabilitation reduces B-type natriuretic peptide.
    Berent R; von Duvillard SP; Crouse SF; Auer J; Green JS; Sinzinger H; Schmid P
    Eur J Cardiovasc Prev Rehabil; 2009 Oct; 16(5):603-8. PubMed ID: 19494782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined endurance/resistance training reduces NT-proBNP levels in patients with chronic heart failure.
    Conraads VM; Beckers P; Vaes J; Martin M; Van Hoof V; De Maeyer C; Possemiers N; Wuyts FL; Vrints CJ
    Eur Heart J; 2004 Oct; 25(20):1797-805. PubMed ID: 15474694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of adding torasemide to standard therapy on peak oxygen consumption, natriuretic peptides, and quality of life in patients with compensated left ventricular systolic dysfunction.
    Gupta S; Waywell C; Gandhi N; Clayton N; Keevil B; Clark AL; Ng LL; Brooks N; Neyses L
    Eur J Heart Fail; 2010 Jul; 12(7):746-52. PubMed ID: 20525705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ivabradine treatment in a chronic heart failure patient cohort: symptom reduction and improvement in quality of life in clinical practice.
    Zugck C; Martinka P; Stöckl G
    Adv Ther; 2014 Sep; 31(9):961-74. PubMed ID: 25160945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The acute effect of Metoprolol upon NT-proBNP level in patients with congestive heart failure.
    Zdrenghea D; Pop D; Ilea M; Bodisz G; Mălai A; Zdrenghea M
    Rom J Intern Med; 2009; 47(1):35-40. PubMed ID: 19886067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Ivabradine on Heart Rate and Duration of Exercise in Patients With Mild-to-Moderate Mitral Stenosis: A Randomized Comparison With Metoprolol.
    Saggu DK; Narain VS; Dwivedi SK; Sethi R; Chandra S; Puri A; Saran RK
    J Cardiovasc Pharmacol; 2015 Jun; 65(6):552-4. PubMed ID: 25636072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of long term therapy with spironolactone on parameters of 24-hour heart rhythm variability and ventricular arrhythmias in patients with heart failure receiving optimal therapy].
    Skvortsov AA; Mareev VIu; Orlova IaA; Chelmakina SM; Baklanova NA; Belenkov IuN
    Kardiologiia; 2008; 48(2):52-64. PubMed ID: 18261010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative Evaluation of -blockers and If-Channel Inhibitor in Patients With Chronic Heart Failure and Preserved Left Ventricular Ejection Fraction].
    Kanorsky SG; Borisenko YV
    Kardiologiia; 2016 Feb; 56(2):24-29. PubMed ID: 28294745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exercise training in advanced heart failure patients: discordance between improved exercise tolerance and unchanged NT-proBNP levels.
    Arad M; Adler Y; Koren-Morag N; Natanzon S; Sela BA; Ben Dov I; Shechter M; Schwammenthal E; Freimark D
    Int J Cardiol; 2008 May; 126(1):114-9. PubMed ID: 17651845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.